Volume 25, Issue S1 p. 528.2-528.2
Biochemistry/Molecular Biology
Free Access

Dietary glycine supplementation mimics lifespan extension by dietary methionine restriction in Fisher 344 rats

Joel Brind,

Natural Sciences, Baruch College, City University of New York, New York, NY

Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY

Search for more papers by this author
Virginia Malloy,

Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY

Search for more papers by this author
Ines Augie,

Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY

Search for more papers by this author
Nicholas Caliendo,

Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY

Search for more papers by this author
Joseph H Vogelman,

Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY

Search for more papers by this author
Jay A. Zimmerman,

Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY

Biology, St. John's University, Queens, NY

Search for more papers by this author
Norman Orentreich,

Orentreich Foundation for the Advancement of Science, Inc., Cold Spring-on-Hudson, NY

Search for more papers by this author

Abstract

Dietary methionine (Met) restriction (MR) extends lifespan in rodents by 30–40% and inhibits growth. Since glycine is the vehicle for hepatic clearance of excess Met via glycine N-methyltransferase (GNMT), we hypothesized that dietary glycine supplementation (GS) might produce biochemical and endocrine changes similar to MR and also extend lifespan. Seven-week-old male Fisher 344 rats were fed diets containing 0.43% Met/2.3% glycine (control fed; CF) or 0.43% Met/4%, 8% or 12% glycine until natural death. In 8% or 12% GS rats, median lifespan increased from 88 weeks (w) to 113 w, and maximum lifespan increased from 91 w to 119 w v CF. Body growth reduction was less dramatic, and not even significant in the 8% GS group. Dose-dependent reductions in several serum markers were also observed. Long-term (50 w) 12% GS resulted in reductions in mean (±SD) fasting glucose (158 ± 13 v 179 ± 46 mg/dL), insulin (0.7 ± 0.4 v 0.8 ± 0.3 ng/mL), IGF-1 (1082 ± 128 v 1407 ± 142 ng/mL) and triglyceride (113 ± 31 v 221 ± 56 mg/dL) levels compared to CF. Adiponectin, which increases with MR, did not change in GS after 12 w on diet. We propose that more efficient Met clearance via GNMT with GS could be reducing chronic Met toxicity due to rogue methylations from chronic excess methylation capacity or oxidative stress from generation of toxic by-products such as formaldehyde. This project received no outside funding.

Journal list menu